Biotech Industry News

A collection of Biotech latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

scmp.com - Reuters - China closing in but US leads in biotech quality and commercial reach: survey
China closing in but US leads in biotech quality and commercial reach: survey
South China Morning Post

China, which now conducts more clinical drug trials than the US, still lags in the quality and commercial reach of its biomedical science, according to a recent survey of senior US leaders in industry and academia. The ‌poll, conducted by…

newsweek.com - Lena Hunter - Field To Future: How Biotech and Business Models Can Change the Food System
Field To Future: How Biotech and Business Models Can Change the Food System
Newsweek

The global food system is entering a critical decade. Resource constraints and consumer expectations are forcing production and supply chains to evolve as the global population inches toward 9 billion by 2050. Yet recent months have laid bare the…

gazette.com - Rachel Gabel - Biotech pigs target alpha-gal meat allergy | Rachel Gabel
Biotech pigs target alpha-gal meat allergy | Rachel Gabel
The Gazette

If I were an evil genius trying to hamstring animal agriculture, I would create a fly that eats livestock alive and a tick whose bite and spit causes some people to have an allergic reaction to meat. (Insert evil laugh here) However, it appears…

fool.com - Josh Kohn-Lindquist - Stock Market Today, June 22: Apogee Therapeutics Soars on AbbVie Cash Buyout Offer
Stock Market Today, June 22: Apogee Therapeutics Soars on AbbVie Cash Buyout Offer
The Motley Fool

Apogee Therapeutics (APGE +46.66%), a clinical-stage biologics company for inflammatory and immunology disorders, closed at $132.55, up 46.66%. AbbVie's proposed $135.11-per-share cash acquisition drove the surge. Investors are watching to see…

globenewswire.com - Zealand Pharma - Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
GlobeNewswire

Company announcement – No. 27 / 2026 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons Copenhagen, Denmark, June 22, 2026 –…

globenewswire.com - Carbios - CARBIOS presents the results of its Annual General Meeting of June 18, 2026
CARBIOS presents the results of its Annual General Meeting of June 18, 2026
GlobeNewswire

Clermont-Ferrand (France), June 22, 2026 (7:45 am CEST). CARBIOS, (Euronext Growth Paris: ALCRB), announces the results of its Annual Ordinary and Extraordinary General Meeting held on June 18, 2026. Shareholders physically present, represented or…

globenewswire.com - Zealand Pharma - Zealand Pharma - Transactions related to share buy-back program (week 25, 2026)
Zealand Pharma - Transactions related to share buy-back program (week 25, 2026)
GlobeNewswire

Company announcement No. 26 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 25, 2026) Copenhagen, Denmark, June 22, 2026 – Zealand Pharma A/S ('the Company' or “Zealand Pharma”) (Nasdaq: ZEAL)…

nasa.gov - Crew Starts Week with Bioengineering, Space Manufacturing, and Spacewalk Preps
Crew Starts Week with Bioengineering, Space Manufacturing, and Spacewalk Preps
NASA

Bioengineering cartilage tissues and manufacturing advanced materials kicked off the week aboard the International Space Station. The Expedition 74 crew members also ramped up preparations for a spacewalk and conducted vision tests on Monday. NASA…

yahoo.com - Abdul Rahman - Is Cogent Biosciences (COGT) 's New Cancer Drug 100 Times More Precise Than What's Already on the Market?
Is Cogent Biosciences (COGT) 's New Cancer Drug 100 Times More Precise Than What's Already on the Market?
Yahoo!

Cogent Biosciences, Inc. (NASDAQ: COGT) is one of the most promising healthcare stocks according to Wall Street analysts. On June 12, Cogent Biosciences, Inc. (NASDAQ:COGT) presented early-stage preclinical data for its experimental drug CGT1145 at…

fool.com - Brendan Coffey - NovoCure vs. Omeros: Which Emerging Pharmaceutical Stock Is a Better Buy in 2026?
NovoCure vs. Omeros: Which Emerging Pharmaceutical Stock Is a Better Buy in 2026?
The Motley Fool

Deciding between NovoCure (NVCR 2.66%) and Omeros (OMER +0.00%) requires a look at two different stages of medical innovation. Both companies aim to solve difficult health challenges using unique scientific approaches. NovoCure is established in…

theguardian.com - Jenna Zaza - Job scams are growing and getting tougher to spot: 'That's the reality of this hell job market'
Job scams are growing and getting tougher to spot: 'That's the reality of this hell job market'
The Guardian

Americans are seeing more employment scams than ever as job seekers, facing a tough job market, report a bombardment of messages from swindlers try to lure them into giving sensitive information. Experts say the technology behind these scams have…

thehindu.com - The Hindu Bureau - Interdisciplinary research will shape future of healthcare: Governor
Interdisciplinary research will shape future of healthcare: Governor
The Hindu

Governor Thaawarchand Gehlot on Monday said that interdisciplinary collaboration and translational research are essential to address the increasingly complex challenges in modern healthcare, and that the future of health sciences lies in the…

businessinsider.com - Sponsor Post - Why Spain is quietly becoming Europe's most important investment platform
Why Spain is quietly becoming Europe's most important investment platform
Business Insider

This spring, executives from 75 multinational companies across 25 countries gathered in Madrid for the Invest in Spain Summit. Their message was consistent: Spain is increasingly seen as one of Europe's most attractive destinations for investment…

heraldscotland.com - Brian Donnelly - 'My career spans diverse geographies and sectors': Scot paves way for major deal
'My career spans diverse geographies and sectors': Scot paves way for major deal
The Herald

Scots-born season ticket holder Mark Hanna said Kadans Science Partner is “focused on advancing and delivering precision medicine technologies through the R&D stage ahead of commercialisation”. The scale of potential achievement has…

news-medical.net - Using the mathematics of quantum mechanics to improve neuroblastoma outcomes
Using the mathematics of quantum mechanics to improve neuroblastoma outcomes
News-Medical

For a child diagnosed with neuroblastoma-the most common infant cancer, occurring when early nerve cells grow out of control-the path to treatment isn't simple. Some types of neuroblastoma resolve on their own, while others require aggressive…

Receive a Daily briefing on Biotech Industry News

Get Started